Skip to main content

Crowley Elizabeth's Form 4 filing

Celldex Therapeutics, Inc. (CLDX) · filed Jun 3, 2024

Accession no.
0001415889-24-015137
Filed
Jun 3, 2024
Trade date
May 30, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.30M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crowley ElizabethCIK 0001681854Officer (SR. VP & CPDO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 30, 2024Common StockMOption exerciseAcquired+34,445$2.78+$95,757.139,171Direct
May 30, 2024Common StockMOption exerciseAcquired+8,500$9.02+$76,67047,671Direct
May 30, 2024Common StockSSaleDisposed−38,597$33.64−$1,298,403.089,074Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 30, 2024Common StockMOption exerciseDisposed−34,445$0.00$00Direct
May 30, 2024Common StockMOption exerciseDisposed−8,500$0.00$07,500Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)